This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Ankylosing Spondylitis, Lumbosacral Region강직척추염, 요천부

ICD-10M45.7
Synonyms / related termsAnkylosing spondylitis with lumbosacral junction involvement, L5-S1 AS, lumbosacral AS
Special Copayment ReductionV140 — Severe intractable disease (copayment 10%, 5 years)
Main age of onsetOnset at ages 15-35; lumbosacral involvement appears together with sacroiliac joint-lumbar involvement

Contents

s1History
s2Causes
s3Genetics
s4General epidemiology
s5Pathophysiology
s6Symptoms
s7Signs
s8Screening
s9Diagnosis
s10Treatment
s11Prognosis
s12Prevention
s13References

1. History

Involvement of the lumbosacral junction (LS junction, L5-S1 region) in ankylosing spondylitis (AS) progresses together with lumbar involvement in the clinical course of AS, and has important clinical significance as the site corresponding to the transition to sacroiliac joint involvement. The LS junction is the spinal region where the greatest compressive load and shear force are concentrated in the upright posture and is a complex anatomical site requiring differentiation from disc herniation and spondylolisthesis. Historically, radiographic changes of lumbosacral AS (L5-S1 discitis, syndesmophytes, facet joint ankylosis) have been described as part of studies of overall lumbar involvement in AS. With advances in MRI technology since the 1990s, active bone marrow edema and anterior corner Romanus lesions of the LS junction began to be identified early. Specific complications of AS at this site include sciatica due to L5-S1 nerve root compression, and fracture and dislocation of the lumbosacral junction after long-standing ankylosis.

2. Causes

The causes of lumbosacral AS combine the risk factors for the onset of systemic AS with the biomechanical environment of this site. HLA-B27, long disease duration, smoking, male sex, and high CRP are risk factors. The L5-S1 junction is the transmission point of weight bearing during standing and walking, so mechanical stress is especially large. Repetitive shear and flexion forces are concentrated at the L5-S1 disc-endplate junction and facet joint entheses, promoting chronic inflammation and bone formation. Discitis at the L5-S1 junction is one of the early changes of AS, and reactive bone formation progresses to L5-S1 syndesmophytes. Anomalous anatomy of the lumbosacral junction (sacralization of L5 or lumbarization of S1) is not uncommon in AS patients, which complicates radiographic evaluation.

3. Genetics

The genetic basis of lumbosacral AS is the same as the genetic factors of systemic AS (HLA-B27, ERAP1, IL23R). Genetic association studies specific to L5-S1 are lacking. Lumbosacral transitional vertebrae (L5 sacralization, S1 lumbarization) are known to have some genetic background, and in AS patients such anatomical variants can cause confusion in radiographic evaluation of AS. Polymorphisms of the DKK-1 and sclerostin genes affect the pattern of bone formation at the LS junction. Osteoporosis-related genetic factors (VDR, LRP5) are associated with the risk of compression fracture at this site.

4. General epidemiology

Separate epidemiologic studies of lumbosacral AS are rare, and it is understood as an extension of lumbar involvement. L5-S1 discitis is observed relatively commonly as an early radiographic change in AS. Syndesmophytes at this site are observed from 5-10 years after the onset of AS, and bony fusion of the L5-S1 segment eventually occurs. Fractures of the lumbosacral junction occur as traumatic or stress fractures after long-standing ankylosis, and because they are difficult to confirm on radiographs, CT is essential. L5-S1 radiculopathy occurs somewhat more frequently in AS patients than in the non-AS population. Separate reports on the frequency of LS junction involvement in Korean AS cohorts are rare.

5. Pathophysiology

The pathology of lumbosacral AS consists of TNF-α/IL-17A-mediated repetitive inflammation and reactive bone formation at the L5-S1 disc-endplate junction, the anterior and posterior longitudinal ligaments, and the facet joint entheses. L5-S1 discitis is a process in which disc tissue is destroyed by autoimmune inflammation of the anterior annulus fibrosus and syndesmophytes form through a reactive endplate response. Synovial inflammation of the facet joints and reactive bone formation cause facet joint ankylosis, and ligamentum flavum hypertrophy contributes to lumbar canal stenosis. When rotational force toward the sacroiliac joint is concentrated in a state of L5-S1 bony fusion after long-standing ankylosis, fracture (chance fracture type) or dislocation at this site is possible. Osteoporotic endplate weakening causes compression fractures.

6. Symptoms

Symptoms of lumbosacral AS are characterized by deep gluteal-lumbar transition pain overlapping with sacroiliac joint pain. The inflammatory pattern of worsening at rest, nocturnal pain, and relief with exercise is typical. With L5-S1 nerve root compression, sciatica (radiating along the posterior thigh-popliteal fossa-posterior leg to the foot), paresthesia of the dorsum of the foot or the heel, and toe dorsiflexion weakness (L5) or plantar flexion weakness (S1) occur. When spondylolisthesis coexists (anterior displacement in a segment with incomplete bony fusion), neurogenic claudication and gait disturbance may appear. Worsening of gluteal-lower limb pain on prolonged standing or walking is characteristic. In a fracture of the lumbosacral junction, sudden worsening of low back pain and onset of neurological symptoms are indicators for emergency treatment.

7. Signs

As main signs of lumbosacral AS, L5-S1 segmental tenderness is identified along with sacroiliac joint tenderness. The Patrick test (FABERE: Flexion, ABduction, External Rotation, Extension) and the Gaenslen test are used to provoke or reproduce combined lumbosacral-sacroiliac joint lesions. In L5/S1 radiculopathy, the patellar tendon reflex (L4, borderline normal), the Achilles tendon reflex (S1, decreased or absent), toe dorsiflexion weakness (L5), and a positive single straight leg raise test are checked. Measurement of the lumbar lordosis angle and assessment of pelvic tilt reflect the functional status of this site. If saddle sensory abnormality is present, involvement of the cauda equina is evaluated immediately.

8. Screening

For screening of lumbosacral AS, anteroposterior pelvic radiographs (including the sacroiliac joints) and lateral lumbar radiographs are performed, and L5-S1 discitis, syndesmophytes, and facet joint ankylosis are evaluated. MRI (lumbar-sacral, T2/STIR) evaluates active L5-S1 bone marrow edema, the activity of discitis, and nerve root compression. CT is essential when a fracture is suspected and is also used to confirm lumbosacral transitional vertebra anatomy. Nerve conduction studies/electromyography are used to confirm L5/S1 radiculopathy. DEXA bone density and regular monitoring with the ASDAS/BASDAI are also performed.

9. Diagnosis

A diagnosis of lumbosacral AS is made when, in a patient meeting AS criteria, radiographic or MRI abnormalities of the lumbosacral junction (L5-S1 discitis, syndesmophytes, facet joint ankylosis, active bone marrow edema) are identified. For differentiation from degenerative lumbar disease (L5-S1 disc herniation, degenerative changes of the facet joints), radiographic morphology, patient age, HLA-B27, and inflammatory markers are used. Code selection between sacroiliac joint involvement (M45.8) and lumbar involvement (M45.6) depends on the main lesion site. When radiculopathy coexists, the need for surgery is evaluated through neurosurgical consultation.

10. Treatment

Drug treatment of lumbosacral AS follows the standard systemic AS protocol (NSAIDs first line, TNF/IL-17 inhibitors second line). When L5-S1 radiculopathy is present, neuropathic pain treatment (gabapentin, pregabalin) may be added. Epidural steroid injection is used selectively for acute radiating pain due to nerve root compression, but its long-term effect in AS is limited. When nerve root decompression is needed, minimally invasive surgery (endoscopic lumbar surgery or TLIF) is considered, but planning that takes into account the fragile bone quality and different spinal anatomy of AS patients is needed. Physical therapy (lumbar stabilization exercises, pelvic tilt correction, gait rehabilitation) is added. Osteoporosis treatment and fall prevention are essential for reducing the risk of lumbosacral fracture.

11. Prognosis

The prognosis of lumbosacral AS is determined by whether radiculopathy coexists, instability of the lumbosacral junction, and the severity of osteoporosis. Stable lumbosacral involvement without neurological symptoms can maintain function with drug treatment and rehabilitation. L5/S1 radiculopathy can recover with early decompression, but incomplete recovery remains when axonal damage from persistent compression has progressed. When bony fusion of the lumbosacral junction is complete, pain decreases but functional limitations persist. TNF/IL-17 inhibitor administration can slow the rate of L5-S1 discitis and syndesmophyte formation. Early detection of radiographic progression and neurological abnormalities through regular follow-up is important for long-term functional outcomes.

12. Prevention

Prevention of lumbosacral AS consists of early diagnosis, thorough anti-inflammatory treatment, smoking cessation, and lumbar-lumbosacral stabilization exercises. Posture education is needed to minimize behaviors that place excessive mechanical load on the L5-S1 region (excessive lumbar flexion, lifting heavy loads). Osteoporosis prevention (calcium, vitamin D, bisphosphonates) and fall prevention contribute to reducing the risk of lumbosacral fracture. Regular MRI and neurological examination allow early detection of L5/S1 radiculopathy. Exercise rehabilitation specific to this site is continued along with systemic AS management (NSAIDs, TNF/IL-17 inhibitors).

13. References

1. van der Linden S, et al. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27(4):361-8.

2. Sieper J, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61(Suppl 3):iii8-18.

3. Braun J, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896-904.

4. Poddubnyy D, et al. Rates and predictors of radiographic spinal progression in AS. Ann Rheum Dis. 2011;70(8):1369-74.

5. Baraliakos X, et al. MRI in AS: patterns of spinal changes. Rheumatology. 2017;56(3):421-32.

6. Reveille JD. Genetics of spondyloarthritis — beyond the MHC. Nat Rev Rheumatol. 2012;8(5):296-304.

7. Klingberg E, et al. Osteoporosis in ankylosing spondylitis — prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012;14(3):R108.

8. Ramiro S, et al. ASAS-EULAR recommendations for AS management: 2022 update. Ann Rheum Dis. 2023;82(1):19-34.

9. Kim TH, et al. Spondyloarthropathies in Korea: prevalence and clinical characteristics. J Korean Med Sci. 2021;36(12):e96.

10. Wanders AJ, et al. NSAIDs inhibit radiographic progression in AS. Arthritis Rheum. 2005;52(6):1756-65.